Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_68235a5e3014d64e15d3c31ce7860832 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-215 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-215 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 |
filingDate |
2020-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2021-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6496c67eed779964622c53cb3702d8b2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_235174dde775ad42d0c804ee08475dfc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4087934c9622a924612b970fea862c4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a6888ae405d88b9536dc132ca332b81 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ca62d90690c84c1c7d96c70715d1c50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8ed0c319b3c6b0687aa8430a0c40481 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8cab7295c144a61a30136a43f6eb643b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8acfc084f4e6a55cf53d26b9692eae0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0272660cfa2cde2883aec58dd1b9c8f4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02451f9b8268a06cf902b656e5206c77 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_edfacbb992a778430337e56b1ad2452b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1caec0b95cb7c30590212e0f1dda62c |
publicationDate |
2021-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
RU-2743594-C1 |
titleOfInvention |
Peptide immunogens used as components of vaccine composition against covid-19 |
abstract |
FIELD: biotechnology.SUBSTANCE: invention relates to biotechnology. Disclosed are the following peptide immunogens: the first peptide immunogen used as a component of vaccine composition against COVID-19 characterized by an amino acid sequence (SEQ ID NO: 2); the second peptide immunogen used as a component of a vaccine against COVID-19 characterized by an amino acid sequence (SEQ ID NO: 3).EFFECT: peptide immunogens that carry the minimum required antigenic determinants for the formation of a specific immune response and induce protective immunity against COVID-19.2 cl, 5 dwg, 4 tbl, 7 ex |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115300608-A |
priorityDate |
2020-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |